Health

Results: 613-624 of 6122

SciBase reaches milestone with over 300,000 patients tested with Nevisense

Vice-President Ambroise Fayolle, EIB and Frederic Desdouits, CEO TreeFrog Therapeutics sign financing of €30million to accelerate cell therapy programs.

TreeFrog Therapeutics Secures €30 Million From European Investment Bank (EIB) Marking a Significant Milestone in the Company’s Journey to Accelerate the Field of Cell Therapy

HER2DX studies presented at ASCO.

ASCO 2025: REVEAL GENOMICS Unveils New HER2DX Data From 800+ Patients

PR Newswire associated0

Announcement of The Shaw Laureates 2025

BeiGene Receives Positive CHMP Opinion for TEVIMBRA® as a First-Line Treatment for Nasopharyngeal Cancer

Faster cancer treatment thanks to new radiotherapy machines

Group photo management AOP Health and RHEACELL, from left to right: Dr. Christoph Ganss, Dr. Andreas Kluth, RHEACELL Dr. Rudolph Widmann, Dr. Günther Krumpl, Dr. Martin Steinhart, Bernhard Nachbaur, LL.M., AOP Health

RHEACELL and AOP Health: Strategic Partnership to Deliver Breakthrough Therapies for the “Butterfly Children’s Disease” and Chronic Venous Wounds

Inter Scientific Achieves UK GLP Monitoring Authority Status to Support Regulatory Studies for Medicines, Devices and Novel Products

PR Newswire associated0

BC Platforms Appoints Senior Product and Marketing Executives to Further Advance Global Expansion and Real-World Data Leadership

World-Leading Cancer Center, The Royal Marsden NHS Foundation Trust, Using AI to Push Boundaries of Cancer Research With NTT DATA and CARPL.ai

Implantica's RefluxStop™ stimulates intensive dialogue at DDW, the world's largest Digestive Disease conference, held in the U.S.

NEW RAY DOLBY - MARSHALL SCHOLARSHIP FUND ANNOUNCED, ENDOWMENT SUPPORTS THIRD-YEAR DOCTORAL RESEARCH